Rohan V. Ameratunga
Park Rd
Grafton, AUK 1010, New Zealand
Grafton, AUK 1010, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
COVID-19 is a living example of Darwinian natural selection, and SARS-CoV-2 evolution is occurring under (and in) our noses.
Journal: The New Zealand medical journal
Published: October 23, 2025
Opinion: the evolving understanding of polygenic common variable immunodeficiency-like disorders.
Journal: Frontiers in immunology
Published: April 29, 2025
Common Variable Immune Deficiency Disorders (CVID) in the Indigenous Māori of Aotearoa (New Zealand) Are Associated With a High Prevalence of Bronchiectasis and Complete IgA Deficiency.
Journal: Scandinavian journal of immunology
Published: March 16, 2025
Common Variable Immunodeficiency Disorders: A perspective from New Zealand.
Journal: Clinical reviews in allergy & immunology
Published: February 13, 2025
Reference intervals for functional lymphocyte proliferation studies using 3H thymidine uptake in adults.
Journal: Journal of immunological methods
Published: September 21, 2024
New Therapies for Type 1 and Type 2 Hereditary Angioedema.
Journal: The New England journal of medicine
Published: May 31, 2024
Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency Disorders.
Journal: Clinical immunology (Orlando, Fla.)
Published: March 18, 2024
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
Journal: Antiviral research
Published: January 24, 2024
Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation.
Journal: Clinical & translational immunology
Published: January 05, 2024
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing.
Journal: Seminars in arthritis and rheumatism
Published: November 06, 2023
Challenges for gene editing in common variable immunodeficiency disorders: Current and future prospects.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 05, 2023
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19.
Journal: Clinical and experimental immunology
Published: June 08, 2023
Last Updated: 09/26/2026